The decision to discontinue the trials comes shortly after the announcement that COAST missed its primary endpoint.

Intraoperative floppy iris syndrome is associated with an increased rate of severe intraoperative complications and greater ...

Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

The combined companies will operate under the name Kalaris Therapeutics, Inc. and expects to report initial data from part 1 ...

A retrospective study showed that the gender of the ophthalmologist influenced the amount of communication with the patient, ...

The novel nitric oxide-donating bimatoprost eye drop is being clinically developed for the lowering of IOP in patients with ...

The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...

Ambulatory surgical centers are freestanding health care facilities that specialize in providing surgical and diagnostic ...

ZEISS VISULAS Combi is an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp ...

The treatment was approved by China’s National Medical Products Administration (NMPA) and is China's first, and the world’s ...

The system aids in the orthokeratology lens design process by syncing directly with topographers to create precise lens ...

CEO Stephen McLeod, MD, outlines the American Academy of Ophthalmology's commitment to advocating for evidence-based, sustainable, and equitable reforms that prioritize public health and access to ...